Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a …

L Degenhardt, P Webb, S Colledge-Frisby… - The Lancet Global …, 2023 - thelancet.com
Background People who inject drugs are exposed to various and changing risk
environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed …

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage …

L Degenhardt, A Peacock, S Colledge… - The Lancet Global …, 2017 - thelancet.com
Background Sharing of equipment used for injecting drug use (IDU) is a substantial cause of
disease burden and a contributor to blood-borne virus transmission. We did a global …

Mass incarceration, public health, and widening inequality in the USA

C Wildeman, EA Wang - The Lancet, 2017 - thelancet.com
In this Series paper, we examine how mass incarceration shapes inequality in health. The
USA is the world leader in incarceration, which disproportionately affects black populations …

Mental and physical health morbidity among people in prisons: an umbrella review

L Favril, JD Rich, J Hard, S Fazel - The Lancet Public Health, 2024 - thelancet.com
Background People who experience incarceration are characterised by poor health profiles.
Clarification of the disease burden in the prison population can inform service and policy …

[PDF][PDF] Key considerations for differentiated antiretroviral therapy delivery for specific populations: children, adolescents, pregnant and breastfeeding women and key …

World Health Organization - 2017 - apps.who.int
Third-party materials. If you wish to reuse material from this work that is attributed to a third
party, such as tables, figures or images, it is your responsibility to determine whether …

Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care

T Papaluca, L McDonald, A Craigie, A Gibson… - Journal of …, 2019 - Elsevier
Background & Aims Treatment programs for people who inject drugs (PWID), including
prisoners, are important for achieving hepatitis C elimination targets. There are multiple …

Dynamic models of infectious disease transmission in prisons and the general population

ML Ndeffo-Mbah, VS Vigliotti, LA Skrip… - Epidemiologic …, 2018 - academic.oup.com
Incarcerated populations experience elevated burdens of infectious diseases, which are
exacerbated by limited access to prevention measures. Dynamic models are used to assess …

Hepatitis C diagnosis: simplified solutions, predictive barriers, and future promises

I Shahid, AR Alzahrani, SS Al-Ghamdi, IM Alanazi… - Diagnostics, 2021 - mdpi.com
The simplification of current hepatitis C diagnostic algorithms and the emergence of digital
diagnostic devices will be very crucial to achieving the WHO's set goals of hepatitis C …

HIV, prisoners, and human rights

LS Rubenstein, JJ Amon, M McLemore, P Eba, K Dolan… - The Lancet, 2016 - thelancet.com
Worldwide, a disproportionate burden of HIV, tuberculosis, and hepatitis is present among
current and former prisoners. This problem results from laws, policies, and policing practices …

Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries

R Bielen, SR Stumo, R Halford, K Werling, T Reic… - Harm reduction …, 2018 - Springer
Background Current estimates suggest that 15% of all prisoners worldwide are chronically
infected with the hepatitis C virus (HCV), and this number is even higher in regions with high …